Clinical trial
Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide
NCT00608153 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- September 30, 2007
- Enrollment
- 1,773 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
Lead sponsor's other trials
AstraZeneca, most recent start first.
+3,493 more trials See the organization page
Similar trials
Same condition (Essential Hypertension) and phase, most recent start first.
+65 more trials See the condition page